Related Experiment Videos
Mean platelet volume is negatively associated with bone mineral density in postmenopausal women
Xue-song Li1, Ji-rong Zhang, Song-yan Meng
1Department of Orthopedics, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.
Insights
Mean platelet volume (MPV), a marker of platelet activation, is negatively associated with bone mineral density (BMD) in older adults. This finding suggests a potential link between platelet activity and osteoporosis, warranting further investigation into thrombotic risk in osteoporotic patients.
Area of Science:
- Geriatric Medicine
- Hematology
- Orthopedics
Background:
- Osteoporosis (OP) is linked to cardiovascular disease and mortality.
- Platelets are crucial in bone remodeling, and Mean Platelet Volume (MPV) indicates platelet activation.
- MPV is implicated in coronary heart disease, but its relation to OP is under-researched.
Purpose of the Study:
- To investigate the relationship between platelet count, MPV, and bone mineral density (BMD).
- To explore the association between MPV and osteoporosis in a geriatric population.
Main Methods:
- Cross-sectional study of 410 geriatric patients.
- Measurement of biochemical parameters, platelet count, and MPV.
- Assessment of bone mineral density (BMD) at lumbar spine and femoral neck.
Main Results:
- Lower BMD correlated with increased MPV, systolic blood pressure, cholesterol, triglycerides, LDL-C, and fasting plasma glucose.
- A significant negative correlation was found between MPV and BMD at the lumbar spine and femoral neck, even after adjusting for risk factors.
- Multivariate analysis confirmed MPV as a significant predictor of reduced BMD (β = -0.285 for lumbar spine, β = -0.207 for femoral neck).
Conclusions:
- Mean platelet volume (MPV) is negatively correlated with bone mineral density (BMD).
- Elevated MPV may be associated with osteoporosis in the elderly.
- Further research into MPV's role in osteoporosis could aid in assessing thrombotic risk in affected patients.
Abstract:
Osteoporosis (OP) has been associated with cardiovascular disease. More specifically, osteoporosis was found to be an independent predictor of cardiovascular mortality. Recent studies revealed that platelets play a critical role in bone remodeling. Mean platelet volume (MPV) is an early marker of platelet activation, which is involved in the pathophysiology of coronary heart disease. However, little research has been conducted to investigate the relationship between MPV and OP. In this cross-sectional study, we investigated the relationship between platelet count, MPV, and bone mineral density (BMD) in 410 subjects in the geriatric department of the Second Affiliated Hospital, Harbin, China. Different biochemical parameters, platelet count, and MPV were determined, and bone mineral density (BMD) (g/cm(2)) was measured in the osteoporosis, osteopenia, and normal BMD groups. Mean age, systolic blood pressure (SBP), total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), and MPV increased gradually, and body mass index (BMI), decreased as BMD decreased. A negative correlation was present between MPV and the lumbar spine (L2-L4) and femoral neck BMD after adjusting other risk factors. Univariate analysis and multivariate analysis showed that MPV was significantly associated with lumbar spine L2-L4 BMD and femoral neck BMD (β = -0.285, P < 0.001 for lumbar spine L2-L4 BMD; β = -0.207, P < 0.001 for femoral neck BMD in multivariate model). The findings show that MPV is negatively correlated with BMD. Further studies on the involvement of MPV in osteoporosis may contribute to the evaluation of thrombotic risk in elderly patients with osteoporosis.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...